Histogen Inc. — Form D/A
Histogen Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2019-09-18. The offering totals $30.0M, of which $15.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-09-18
- Form: D/A
- Accession: 0001645829-19-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $30.0M
- Amount sold: $15.3M
- Remaining: $14.7M
- Investors: 47
- Date of first sale: 2016-08-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-269733
Issuer
- Name: Histogen Inc.
- CIK: 0001645829
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 10655 SORRENTO VALLEY ROAD, SAN DIEGO, CA, 92121
- Phone: 858-200-9520
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Stephen Chang | Director | Bryn Mawr, PA |
| David Crean | Director | San Diego, CA |
| Jonathan Jackson | Director | Dayton, OH |
| Richard Pascoe | Director | San Diego, CA |
| Brian Satz | Director | San Diego, CA |
| Yizhuo Zhang | Director | San Diego, CA |
| Richard Pascoe | Executive Officer | San Diego, CA |
| Gail Naughton | Director | San Diego, CA |
| Gail Naughton | Executive Officer | San Diego, CA |
Other filings by this issuer (9)
More